AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
Cefditoren pivoxil - A novel broad-spectrum oral cephalosporin
Authors: Kuti, JL Quintiliani, R
Citation: Jl. Kuti et R. Quintiliani, Cefditoren pivoxil - A novel broad-spectrum oral cephalosporin, FORMULARY, 36(4), 2001, pp. 265
Drotrecogin alfa (activated) - A new approach to treating sepsis
Authors: Caron, MR Kuti, JL Quintiliani, R White, CM
Citation: Mr. Caron et al., Drotrecogin alfa (activated) - A new approach to treating sepsis, FORMULARY, 36(11), 2001, pp. 784
Moxifloxacin does increase the corrected QT interval
Authors: White, CM Grant, EM Quintiliani, R
Citation: Cm. White et al., Moxifloxacin does increase the corrected QT interval, CLIN INF D, 33(8), 2001, pp. 1441-1442
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens
Authors: Owens, RC Tessier, P Nightingale, CH Ambrose, PG Quintiliani, R Nicolau, DP
Citation: Rc. Owens et al., Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens, INT J ANT A, 17(6), 2001, pp. 483-489
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
Authors: Nicolau, DP McNabb, J Lacy, MK Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia, INT J ANT A, 17(6), 2001, pp. 497-504
Pharmacokinetic and pharmacodynamic profile of high dose extended intervalpiperacillin-tazobactam
Authors: Kim, MK Xuan, DW Quintiliani, R Nightingale, CH Nicolau, DP
Citation: Mk. Kim et al., Pharmacokinetic and pharmacodynamic profile of high dose extended intervalpiperacillin-tazobactam, J ANTIMICRO, 48(2), 2001, pp. 259-267
Optimizing antiinfective transition therapy in community-acquired pneumonia - Introduction
Authors: Quintiliani, R
Citation: R. Quintiliani, Optimizing antiinfective transition therapy in community-acquired pneumonia - Introduction, PHARMACOTHE, 21(7), 2001, pp. 77S-78S
Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia
Authors: McNabb, JCJ Nightingale, CH Quintiliani, R Nicolau, DP
Citation: Jcj. Mcnabb et al., Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia, PHARMACOTHE, 21(5), 2001, pp. 549-555
Lack of interaction between levofloxacin and oxycodone: Pharmacokinetics and drug disposition
Authors: Grant, EM Zhong, MK Fitzgerald, JF Nicolau, DP Nightingale, C Quintiliani, R
Citation: Em. Grant et al., Lack of interaction between levofloxacin and oxycodone: Pharmacokinetics and drug disposition, J CLIN PHAR, 41(2), 2001, pp. 206-209
Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacinexposure in a rabbit tissue cage model
Authors: Xuan, DW Zhong, MK Mattoes, H Bui, KQ McNabb, J Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Dw. Xuan et al., Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacinexposure in a rabbit tissue cage model, ANTIM AG CH, 45(3), 2001, pp. 794-799
Regulation of VanA- and VanB-type glycopeptide resistance in enterococci
Authors: Arthur, M Quintiliani, R
Citation: M. Arthur et R. Quintiliani, Regulation of VanA- and VanB-type glycopeptide resistance in enterococci, ANTIM AG CH, 45(2), 2001, pp. 375-381
Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients
Authors: Bui, KQ Ambrose, PG Nicolau, DP Lapin, CD Nightingale, CH Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients, CHEMOTHERA, 47(3), 2001, pp. 153-156
Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsis
Authors: Xuan, DW Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Dw. Xuan et al., Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsis, CHEMOTHERA, 47(3), 2001, pp. 194-202
Stability of meropenem in a portable infusion device in a cold pouch
Authors: Grant, EM Zhong, MK Ambrose, PG Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Em. Grant et al., Stability of meropenem in a portable infusion device in a cold pouch, AM J HEAL S, 57(10), 2000, pp. 992-995
Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS
Authors: McNabb, J Owens, RC Xuan, DW Quintiliani, R Nightingale, CH Nicolau, DP
Citation: J. Mcnabb et al., Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS, INT J ANT A, 16(1), 2000, pp. 37-43
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci
Authors: Lacy, MK Tessier, PR Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Mk. Lacy et al., Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci, INT J ANT A, 15(1), 2000, pp. 25-30
Limitations of single point pharmacodynamic analysis
Authors: Ambrose, PG Quintiliani, R
Citation: Pg. Ambrose et R. Quintiliani, Limitations of single point pharmacodynamic analysis, PEDIAT INF, 19(8), 2000, pp. 769-769
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa
Authors: Bui, KQ Banevicius, MA Nightingale, CH Quintiliani, R Nicolau, DP
Citation: Kq. Bui et al., In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa, J ANTIMICRO, 45(1), 2000, pp. 57-62
Cost-effectiveness in the use of antibiotics
Authors: McNabb, J Quintiliani, R Nicolau, DP Grant, E Nightingale, CH
Citation: J. Mcnabb et al., Cost-effectiveness in the use of antibiotics, CURR CLIN I, 20, 2000, pp. 24-42
Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa
Authors: McNabb, J Quintiliani, R Nightingale, CH Nicolau, DP
Citation: J. Mcnabb et al., Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa, CHEMOTHERA, 46(6), 2000, pp. 383-389
Pharmacodynamics and pharmacokinetics of levofloxacin
Authors: Nightingale, CH Grant, EM Quintiliani, R
Citation: Ch. Nightingale et al., Pharmacodynamics and pharmacokinetics of levofloxacin, CHEMOTHERA, 46, 2000, pp. 6-14
Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia
Authors: Nicolau, DP McNabb, JC Lacy, MK Li, J Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia, CLIN DRUG I, 18(2), 1999, pp. 133-139
Pharmacoeconomic analysis of intravenous push vs slow infusion of beta-lactam antibiotics
Authors: Ambrose, PG Bui, KQ Richerson, MA Quintiliani, R Nightingale, C
Citation: Pg. Ambrose et al., Pharmacoeconomic analysis of intravenous push vs slow infusion of beta-lactam antibiotics, CLIN DRUG I, 17(5), 1999, pp. 407-410
Pharmacokinetics and pharmacoeconomic evaluation of ticarcillin-clavulanate administered as either continuous or intermittent infusion with once-daily gentamicin
Authors: Bui, KQ Ambrose, PG Grant, E Nightingale, CH Nicolau, DP Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics and pharmacoeconomic evaluation of ticarcillin-clavulanate administered as either continuous or intermittent infusion with once-daily gentamicin, INF DIS C P, 8(9), 1999, pp. 449-455
Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia
Authors: Ambrose, PG Richerson, MA Stanton, ME Bui, K Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Pg. Ambrose et al., Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia, INF DIS C P, 8(5), 1999, pp. 245-251
Risultati: 1-25 | 26-36